Press release
Non-Muscle Invasive Bladder (NMIBC) Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Bristol-Myers Squibb, Pfizer, Asieris, Incyte, Janssen, Theralase, Vaxiion Therapeutics
"Non-Muscle Invasive Bladder Cancer (NMIBC) Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Non-Muscle Invasive Bladder Cancer Therapeutics Market.
The report provides a detailed description of the Non-Muscle Invasive Bladder Cancer drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Non-Muscle Invasive Bladder Cancer Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/non-muscle-invasive-bladder-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Non-Muscle Invasive Bladder Cancer (NMIBC) Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Non-Muscle Invasive Bladder Cancer therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Non-Muscle Invasive Bladder Cancer treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Non-Muscle Invasive Bladder Cancer drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Non-Muscle Invasive Bladder Cancer treatment market.
Learn More about the Clinical and Commercial Development Activities in the Non-Muscle Invasive Bladder Cancer Therapeutics Domain @
https://www.delveinsight.com/report-store/non-muscle-invasive-bladder-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Non-Muscle Invasive Bladder Cancer (NMIBC) Therapeutics Analysis
NMIBC remains a very challenging disease to treat with high rates of recurrence and progression associated with current therapies. The high rates of progression and recurrence with current therapies for NMIBC necessitate lifelong active surveillance, making bladder cancer the most expensive cancer to treat from diagnosis to death, as well as driving the need for the development of new therapies in patients with NMIBC.
The current Non-Muscle Invasive Bladder Cancer (NMIBC) treatment regimen includes KEYTRUDA (pembrolizumab), ADSTILADRIN, surgery, intravesical immunotherapy (BCG) and intravesical chemotherapy.
Intermediate- or high-risk NMIBC is generally treated with transurethral resection of bladder tumor (TURBT), followed by adjuvant BCG immunotherapy which is the gold standard treatment for reducing tumor recurrence rates and preventing subsequent stage progression. Stage 0 bladder cancer is most often treated with TURBT with fulguration followed by intravesical therapy within 24 h. Sometimes no further treatment is needed. Cystoscopy is then done every 3-6 months to watch for signs that cancer has come back. Valrubicin might be used if BCG stops working. But not all experts agree on this treatment.
FDA has approved many drugs for the treatment of bladder cancer but to date there are only two drugs which are being given for the treatment of NMIBC which include KEYTRUDA and ADSTILADRIN, approved in 2020 and 2022, respectively. There are approx. 25+ key companies developing therapies for Non-Muscle Invasive Bladder Cancer. Currently, Asieris Pharmaceuticals is leading the therapeutics market with its Non-Muscle Invasive Bladder Cancer drug candidates in the most advanced stage of clinical development.
Non-Muscle Invasive Bladder Cancer (NMIBC) Companies in the Therapeutics Market Include:
• Bristol-Myers Squibb
• Pfizer
• Asieris Pharmaceuticals
• Incyte Corporation
• Janssen Pharmaceuticals
• Theralase Technologies
• Aura Biosciences
• Protara Therapeutics
• Vaxiion Therapeutics
• Tollys
And Many Others
Emerging and Marketed Non-Muscle Invasive Bladder Cancer (NMIBC) Therapies Covered in the Report Include:
• APL-1202: Asieris Pharmaceuticals
• Pemigatinib: Incyte Corporation
• VAX 014: Vaxiion Therapeutics
And Many More
Get an in-depth Assessment of the Emerging Therapies and Non-Muscle Invasive Bladder Cancer Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/non-muscle-invasive-bladder-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Non-Muscle Invasive Bladder Cancer Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
Non Muscle Invasive Bladder Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Intravenous
• Subcutaneous
• Parenteral
• Topical
Molecule Type
Products have been categorized under various Molecule types such as
• Recombinant fusion proteins
• Small molecule
• Monoclonal antibody
• Peptide
• Polymer
• Gene therapy
Request for Sample PDF to Understand More About the Non-Muscle Invasive Bladder Cancer Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/non-muscle-invasive-bladder-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Non-Muscle Invasive Bladder Cancer Current Treatment Patterns
4. Non-Muscle Invasive Bladder Cancer - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Non-Muscle Invasive Bladder Cancer Late-Stage Products (Phase-III)
7. Non-Muscle Invasive Bladder Cancer Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Non-Muscle Invasive Bladder Cancer Discontinued Products
13. Non-Muscle Invasive Bladder Cancer Product Profiles
14. Non-Muscle Invasive Bladder Cancer Companies
15. Non-Muscle Invasive Bladder Cancer Drugs
16. Dormant and Discontinued Products
17. Non-Muscle Invasive Bladder Cancer Unmet Needs
18. Non-Muscle Invasive Bladder Cancer Future Perspectives
19. Non-Muscle Invasive Bladder Cancer Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/non-muscle-invasive-bladder-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research
Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices
Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology
Other Trending Healthcare Reports by DelveInsight
Functional Electrical Stimulation (FES) Devices Market
https://www.delveinsight.com/report-store/functional-electrical-stimulation-fes-devices-market
Hypoactive Sexual Desire Disorder Market
https://www.delveinsight.com/report-store/hypoactive-sexual-desire-disorder-hsdd-market
Complicated Intra-Abdominal Infections Market
https://www.delveinsight.com/report-store/complicated-intra-abdominal-infections-market
Malignant Pleural Mesothelioma (MPM) Market
https://www.delveinsight.com/report-store/malignant-pleural-mesothelioma-market
Mitochondrial Myopathies Market
https://www.delveinsight.com/report-store/mitochondrial-myopathies-market
Asthma Diagnostic Devices Market
https://www.delveinsight.com/report-store/asthma-diagnostic-devices-market
Mayus Kinase (jak) Inhibitors Market
https://www.delveinsight.com/report-store/mayus-kinase-inhibitors-market
Acute Heart Failure Market
https://www.delveinsight.com/report-store/acute-heart-failure-ahf-market
Bacterial Vaginosis Market
https://www.delveinsight.com/report-store/bacterial-vaginosis-market
Hyperphosphatemia Market
https://www.delveinsight.com/report-store/hyperphosphatemia-market
Pleural Effusion Market
https://www.delveinsight.com/report-store/pleural-effusion-market
Epidermolysis Bullosa Market
https://www.delveinsight.com/report-store/epidermolysis-bullosa-market
Gestational Diabetes Market
https://www.delveinsight.com/report-store/gestational-diabetes-market
Intratumoral Cancer Therapies Market
https://www.delveinsight.com/report-store/intratumoral-cancer-therapies-market
Wasting Syndrome Market
https://www.delveinsight.com/report-store/wasting-syndrome-market
Parkinson's Disease Related Dementia Market
https://www.delveinsight.com/report-store/parkinsons-disease-related-dementia-market
Vagus Nerve Stimulator (VNS) Global Market
https://www.delveinsight.com/report-store/vagus-nerve-stimulator-market
Abetalipoproteinemia Market
https://www.delveinsight.com/report-store/abetalipoproteinemia-market
Myelofibrosis (MF) Market
https://www.delveinsight.com/report-store/myelofibrosis-mf-market
Chemotherapy Induced Neutropenia (CIN) Market
https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market
Homozygous Familial Hypercholesterolemia Market
https://www.delveinsight.com/report-store/homozygous-familial-hypercholesterolemia-market
Partial Onset seizures Market
https://www.delveinsight.com/report-store/partial-onset-seizures-market
West Nile Encephalitis Market
https://www.delveinsight.com/report-store/west-nile-encephalitis-market
Gonorrhea Market
https://www.delveinsight.com/report-store/gonorrhea-market
Polymyositis Market
https://www.delveinsight.com/report-store/polymyositis-market
Subarachnoid Hemorrhage Market
https://www.delveinsight.com/report-store/subarachnoid-hemorrhage-market
Acute Pancreatitis Market
https://www.delveinsight.com/report-store/acute-pancreatitis-market
Acute Respiratory Distress Syndrome (ARDS) Market
https://www.delveinsight.com/report-store/acute-respiratory-distress-syndrome-ards-market
Hypercoagulability Market
https://www.delveinsight.com/report-store/hypercoagulability-market
PARP Inhibitors Market
https://www.delveinsight.com/report-store/parp-inhibitors-competitive-landscape-pipeline-and-market-analysis
Bacterial Conjunctivitis Market
https://www.delveinsight.com/report-store/bacterial-conjunctivitis-market
Desmoplastic Small Round Cell Tumors (DSRCTS) Market
https://www.delveinsight.com/report-store/desmoplastic-small-round-cell-tumors-market
Hemophilia with Inhibitor Market
https://www.delveinsight.com/report-store/hemophilia-with-inhibitor-market
Pelvic Inflammatory Disease Market
https://www.delveinsight.com/report-store/pelvic-inflammatory-disease-market
Hemorrhoids Market
https://www.delveinsight.com/report-store/hemorrhoids-market
PCSK9 Inhibitors Market
https://www.delveinsight.com/report-store/pcsk9-inhibitors-market
Stargardt Disease (STGD) Market
https://www.delveinsight.com/report-store/stargardt-disease-stgd-market
Dravet Syndrome Market
https://www.delveinsight.com/report-store/dravet-syndrome-market
Genital Warts Market
https://www.delveinsight.com/report-store/genital-warts-condyloma-acuminatum-market
Orthopedic Trauma Devices Market
https://www.delveinsight.com/report-store/orthopedic-trauma-devices-market
Acute Lymphoblastic Leukemia (ALL) Market
https://www.delveinsight.com/report-store/acute-lymphoblastic-leukemia-all-market
Erythema Market
https://www.delveinsight.com/report-store/erythema-market
Primary Open Angle Glaucoma (POAG) Market
https://www.delveinsight.com/report-store/primary-open-angle-glaucoma-poag-market
Cutaneous Lupus Erythematosus Market
https://www.delveinsight.com/report-store/cutaneous-lupus-erythematosus-cle-market
Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP) Market
https://www.delveinsight.com/report-store/hospital-acquired-and-ventilator-associated-bacterial-pneumonia-market
Traumatic Brain Injury Assessment Devices Market
https://www.delveinsight.com/report-store/traumatic-brain-injury-assessment-management-devices-market
Cartilage Diseases Market
https://www.delveinsight.com/report-store/cartilage-diseases-market
Hormone Sensitive Advanced Prostate Cancer Market
https://www.delveinsight.com/report-store/hormone-sensitive-advanced-prostate-cancer-market
Neuromodulation Devices Global Market
https://www.delveinsight.com/report-store/neuromodulation-devices-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Muscle Invasive Bladder (NMIBC) Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Bristol-Myers Squibb, Pfizer, Asieris, Incyte, Janssen, Theralase, Vaxiion Therapeutics here
News-ID: 3312212 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Invasive
Non-Invasive Invasive Laser Lipolysis Machine Market Size, Share and Growth Repo …
On May 9, 2025, Exactitude Consultancy., Ltd. released a research report titled "Non-Invasive Invasive Laser Lipolysis Machine Market". This report covers the global Non-Invasive Invasive Laser Lipolysis Machine market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034…
Aesthetic Medicine Market, By Procedure Type (Invasive Procedures, Non-invasive …
Aesthetic medicine is a type of cosmetic procedure which is used in the treatment to improve scars, wrinkles, liver spots, cellulite, unwanted hair, excess fat and others that will help in augmenting the physical appearance of the patient using minimally invasive and non-invasive procedure.
View Detailed Report: https://www.databridgemarketresearch.com/reports/global-aesthetic-medicine-market
Data Bridge Market Research analyses that the aesthetic medicine market is expected to reach the value of USD 26.68 Billion by the year 2029,…
Minimally Invasive Surgical Instruments Market - Driving Surgical Excellence wit …
Newark, New Castle, USA: The "Minimally Invasive Surgical Instruments Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Minimally Invasive Surgical Instruments Market: https://www.growthplusreports.com/report/minimally-invasive-surgical-instruments-market/7672
This latest report researches the…
Minimally Invasive And Non Invasive Product And Service Market Market Trends Ana …
The research report on the Global Minimally Invasive And Non-Invasive Product And Service Market offers numerous market frameworks, including market size, portion, trends, growth path, value, and factors that affect the current market dynamics throughout the projected period of 2022-2030. Most importantly, along with their market shares, this research also includes the most essential recent strategies used by major companies. The market for minimally invasive and non-invasive goods and services…
Micro-Invasive Glaucoma Implants Micro-Invasive Glaucoma Implants
Global Micro-Invasive Glaucoma Implants Market Definition: Micro-invasive glaucoma implants is performed for the treatment of the open- angle glaucoma and is done through an ab- interno approach. It is very safe and provides faster recovery as compared to the traditional methods. They usually lower the intraocular by increasing the flow or reducing the production of the aqueous humor. Increasing cases of the glaucoma worldwide is the major factor fueling the…
Respiratory Humidification Market for Invasive & Non-Invasive Ventilation | Late …
Researchmoz added Most up-to-date research on "Respiratory Humidification Market (Controller & Consumables) for Invasive & Non-Invasive Ventilation" to its huge collection of research reports.
Respiratory humidification is a method of artificial warming and humidifying of respiratory gas for mechanically ventilated patients. It is a method of artificially conditioning respiratory gas for the patient during therapy. Humidifiers are used in respiratory and acute care (RAC) and for the treatment of sleep apnea.…
